JT, It very coincidental that it is appx 6 weeks away from the 2qtr earnings, lol. To rise like this with no new announcements seems to be a signal, I guess.
BB, on Friday the volume was 510,000 shares which was on par with the institutional rebalancing on June 16th, where volume was 535,000 shares. There were no announcements on Friday.
It makes me wonder if they made an 505(b)2 NDA filing for oral liquid form of Terazosin. I imagine they would not make any announcement until it is accepted and a PDUFA date has been assigned. It would fit within a timeline of 2024 launch as projected in their SEC filings.